Hypertrophic Cardiomyopathy: Novel Predictors of Outcome (CHRISTOPHER M. KRAMER, MD) March 22, 2018
“Hypertrophic Cardiomyopathy: Novel Predictors of Outcome”
Houston Methodist DeBakey Heart & Vascular Center, Grand Rounds Conference featuring CHRISTOPHER M. KRAMER, MD as he discusses “Hypertrophic Cardiomyopathy: Novel Predictors of Outcome".
Introduction & Moderator: WILLIAM A. ZOGHBI, MD
Featured Speaker: CHRISTOPHER M. KRAMER, MD
_______________________________________________________________
HOUSTON METHODIST DEBAKEY HEART & VASCULAR CENTER
GRAND ROUNDS
STATEMENT OF NEED
This program is designed, in light of reviewing quality data retrieved from weekly evaluations, to provide physicians, faculty, fellows and residents access to topics in current basic and clinical research to improve patient care.
TARGET AUDIENCE
The target audience for this activity is: Cardiology and Cardiovascular Surgery Physicians, Fellows, Residents, NPs,
PAs, Nurses, Radiologic Technologists, Sonographers and Research Coordinators.
EDUCATIONAL OBJECTIVES
At the conclusion of this activity, the participant should be able to:
• Discuss updates on diagnosis, treatment and management of cardiovascular disease.
• Integrate data and available technique in order to reach appropriate treatment decisions.
• Describe research models, methods and statistical tools.
Видео Hypertrophic Cardiomyopathy: Novel Predictors of Outcome (CHRISTOPHER M. KRAMER, MD) March 22, 2018 канала Houston Methodist DeBakey CV Education
Houston Methodist DeBakey Heart & Vascular Center, Grand Rounds Conference featuring CHRISTOPHER M. KRAMER, MD as he discusses “Hypertrophic Cardiomyopathy: Novel Predictors of Outcome".
Introduction & Moderator: WILLIAM A. ZOGHBI, MD
Featured Speaker: CHRISTOPHER M. KRAMER, MD
_______________________________________________________________
HOUSTON METHODIST DEBAKEY HEART & VASCULAR CENTER
GRAND ROUNDS
STATEMENT OF NEED
This program is designed, in light of reviewing quality data retrieved from weekly evaluations, to provide physicians, faculty, fellows and residents access to topics in current basic and clinical research to improve patient care.
TARGET AUDIENCE
The target audience for this activity is: Cardiology and Cardiovascular Surgery Physicians, Fellows, Residents, NPs,
PAs, Nurses, Radiologic Technologists, Sonographers and Research Coordinators.
EDUCATIONAL OBJECTIVES
At the conclusion of this activity, the participant should be able to:
• Discuss updates on diagnosis, treatment and management of cardiovascular disease.
• Integrate data and available technique in order to reach appropriate treatment decisions.
• Describe research models, methods and statistical tools.
Видео Hypertrophic Cardiomyopathy: Novel Predictors of Outcome (CHRISTOPHER M. KRAMER, MD) March 22, 2018 канала Houston Methodist DeBakey CV Education
Показать
Комментарии отсутствуют
Информация о видео
17 апреля 2018 г. 0:15:05
00:59:35
Другие видео канала
![Contrast Echo (William A. Zoghbi, MD) May 5, 2020](https://i.ytimg.com/vi/CZWF0aX7Prc/default.jpg)
![Hypertrophic Cardiomyopathy (HCM): Innovative Options for Treatment](https://i.ytimg.com/vi/qnI5jL3sh7g/default.jpg)
![Hypertrophic cardiomyopathy: Mayo Clinic’s approach to diagnosing and treating.](https://i.ytimg.com/vi/ala3CL2aPyY/default.jpg)
![Town Hall Conversation XI: The Front Lines of the Fight Against COVID‑19 (Marc L. Boom, MD) 02/03/21](https://i.ytimg.com/vi/ZNkh3d_vPRo/default.jpg)
![Management of Aortic Dissection (Marvin Atkins, MD)](https://i.ytimg.com/vi/-CbULp7v4Hc/default.jpg)
![Cardiomyopathies II: Restrictive and Inflammatory (D. Shah, MD; M. Al Mallah, MD) February 2, 2021](https://i.ytimg.com/vi/kyOeFw20goQ/default.jpg)
![Heart Failure Not Due to Coronary Artery Disease or Hypertension (BARRY TRACHTENBERG, MD)](https://i.ytimg.com/vi/hTxp3SlxDw4/default.jpg)
![Hypertrophic Obstructive Cardiomyopathy (HOCM)](https://i.ytimg.com/vi/gOFk_uJURpE/default.jpg)
![Reducing CVD Residual Risk Reduction with Icosapent Ethyl (K. Nasir, MD & guests) February 3, 2021](https://i.ytimg.com/vi/P2cR0pCIWpQ/default.jpg)
![Thoracic Aortic Disease (Thomas E. MacGillivray, MD)](https://i.ytimg.com/vi/aHrHLbMXoSc/default.jpg)
![Multimodality imaging in cardiac Sarcoidosis: Dr Christine Jellis (Cleveland Clinic)](https://i.ytimg.com/vi/OQEqY6de1C4/default.jpg)
![Current Status of Vena Cava Filters (Ulises Baltazar, MD; Jean Bismuth, MD) January 27, 2021](https://i.ytimg.com/vi/FrfpgRmKvxE/default.jpg)
![Hypertrophic Cardiomyopathy (HCM) Mechanism of Disease Video](https://i.ytimg.com/vi/_K1F3bHyELo/default.jpg)
![Obstructive Hypertrophic Cardiomyopathy: Ben’s HCM Patient Story](https://i.ytimg.com/vi/Vk36SFNS5GA/default.jpg)
![Basic Principles of Echocardiography and Doppler (William A. Zoghbi, MD) September 10, 2019](https://i.ytimg.com/vi/xO2kABjXQBM/default.jpg)
![Grand Rounds - Acute Myocarditis and Fulminant Myocarditis](https://i.ytimg.com/vi/xjFb1PrPPls/default.jpg)
![Exercise and Lifestyle with Cardiomyopathy](https://i.ytimg.com/vi/11zphawmFW8/default.jpg)
![COVID-19 Vaccine Town Hall–Houston Minority Supplier Development Council (Marc L. Boom, MD) 01/29/21](https://i.ytimg.com/vi/piQpgLDJJ7E/default.jpg)
![RV Function (Logan Kosarek, MD)](https://i.ytimg.com/vi/OsyuQI5NTEw/default.jpg)
![Venturing into the Digital CV World (M.Quiñones, MD; A. Soliman, MD; W. Zoghbi, MD) January 26, 2021](https://i.ytimg.com/vi/rKOUOWda5bg/default.jpg)